Latest Texas Children's Cancer Center Stories
HOUSTON, April 15 /PRNewswire-USNewswire/ -- Nine-year-old Morgan LaRue is the first cancer patient in Texas to benefit from a groundbreaking procedure that will magnetically lengthen her leg, sparing her the possibility of up to 10 future surgeries as her body grows.
- Will Lead Children's Oncology Group -- Collaborative Organization in Pediatric Cancer - PHILADELPHIA, Dec. 7 /PRNewswire-USNewswire/ -- Peter C.
DALLAS, Nov. 24 /PRNewswire-USNewswire/ -- The Baylor Charles A. Sammons Cancer Center has become a full member of one of the largest cancer clinical trials cooperative groups in the United States.
A grant from the Liddy Shriver Sarcoma Initiative will allow Dr. Pulivarthi Rao, associate professor of pediatrics at Baylor College of Medicine, and his team of researchers to explore the role of the gene CDC5L in the development of osteosarcoma, the most common bone cancer in children.
Teenagers who are diagnosed with cancer face issues that younger patients do not, but fortunately programs have emerged at the Texas Childrenâ€™s Cancer Center (www.txccc.org) and others across the country geared just for them.
Texas Children's Cancer Center today launched Passport for Care, an innovative Web-based application that provides childhood cancer survivors and their physicians with immediate access to a survivor's diagnosis and treatment history.
Neogenix Oncology, Inc. (Neogenix) announced today that Philip M. Arlen, MD, was elected to the Board of Directors at its August 2008 meeting. The company also announced that Dr. Arlen had accepted the company's offer to become President and Chief Medical Officer, effective immediately. Dr.